Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal Transplantation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 21, 2020

Primary Completion Date

November 21, 2023

Study Completion Date

December 21, 2023

Conditions
Diabetes Mellitus
Interventions
DEVICE

Continuous Glucose Monitor Application

The Guardian™ Sensor glucose sensor is part of the Medtronic Continuous Glucose Monitoring (CGM) system. The system then uses these signals to provide sensor glucose values. Patients post-renal transplantation will have CGMs applied and values interpreted by nursing.

DIAGNOSTIC_TEST

Finger Stick Glucose Measurement

Patients post-renal transplant will have finger-stick glucose measurements checked prior to meals.

DRUG

Insulin

Insulin will be administered.

DEVICE

Continuous Glucose Monitor Placebo Applied

The Guardian™ Sensor glucose sensor is part of the Medtronic Continuous Glucose Monitoring (CGM) system. The system then uses these signals to provide sensor glucose values. Patients post-renal transplantation will have CGMs applied however values will not be interpreted.

Trial Locations (1)

11030

North Shore University Hospital, Manhasset

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER